Examination of HbA1c and lipid values in patients diagnosed with diabetes mellitus with respect to different regions in Turkey


ÖZTAŞ D., BALCIOĞLU H., Sari Y. E., Sağlan Y., BİLGE U.

Biomedical Research (India), vol.28, no.20, pp.8887-8895, 2017 (Scopus) identifier

  • Publication Type: Article / Article
  • Volume: 28 Issue: 20
  • Publication Date: 2017
  • Journal Name: Biomedical Research (India)
  • Journal Indexes: Scopus
  • Page Numbers: pp.8887-8895
  • Keywords: Target rate, Type 2 diabetes mellitus
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Aim: The aim of the present study is to investigate the distribution of HbA1c, LDL, TG, HDL and non- HDL-cholesterol values based on different regions in Turkey as well as sexes; and to determine the differences between regions and sexes in order to achieve target values in 11 health regions of Turkey as defined by the classification of regional units for statistics. Methods: All data recorded on computers by primary care family physicians are archived by the Ministry of Health, General Directorate of Information Systems. These data included 11 regions based on the classification of regional units for statistics and age, sex, LDL, TG, HDL, total cholesterol and HbA1c (%) of patients. The data obtained will be grouped with respect to regions. Results: When the compatibility of the blood values for all population are evaluated in relation to the target value; it was found that 5756 (50.4%) individuals were within the target range for HbA1c (6.5%), and 7484 (65.5%) individuals were within the target range for HbA1c (7.0%). 2225 (24.2%) individuals were within the target range for LDL, 4633 (49.8%) individuals for TG, 4776 (50.2%) individuals for HDL, and 1981 (24.5%) individuals for non-HDL cholesterol. Conclusion: According to the findings of this study, the rate of achieving the target values in type 2 diabetic patients in Turkey are still inadequate. To this end, novel regional and country-wide health improving policies are required. Patient education, continuing medicine training for physicians and local guidelines may assist in the follow-up and treatment of DM.